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Background. The blastic crisis of chronic myeloid leukemia (CML-BC) is usually the final 
phase of the disease, in which the percentage of the young, often undifferentiated cells, known as 
blastocytes gets above 20%. Nowadays, in the era of the therapy with Tyrosine Kinase 
Inhibitors, the transformation from CML to CML-BC occurs much later and more rarely.  
Case report. We present the case of a 71 year old male, admitted in July 2017, to the 
Haematology Unit of Mures County Emergency Hospital presenting severe anemia, 
leukocytosis, leukocyte left shift, absence of the leukemic hiatus and thrombocytopenia. 
Splenomegaly (7 - 9 cm) was also found. Cytogenetic examination revealed the presence of 
Philadelphia chromosome and real-time PCR showed 87% positivity for BCR-ABL. Chronic 
Myeloid Leukemia was the diagnosis and treatment with Dasatinib was initiated. A month after 
the patient develops severe thrombocytopenia and hemorrhagic purpura. Treatment was 
interrupted until the platelet count was restored and continued after with smaller dosage. 
Erythrocyte mass was transfused in order to correct the anemia. Three months after the diagnosis 
with CML, spleen expansion and hyperleukocytosis was observed. The peripheral blood smear 
indicated high blastocyte percentage (88%) and the patient was admitted and diagnosed with 
CML-BC. The diagnosis was confirmed, RT-PCR still showed positivity for BCR-ABL in 48%. 
Induction treatment for Acut Lymphoblastic Leukemia with adapted protocol for elderly patient 
with comorbidities was initiated. In December 2017 the patient refuses further treatment and 
unfortunately passes away. 
Conclusion. Chronic myeloid leukemia is a condition with a high survival rate, especially after 
introducing the tyrosine kinase inhibitors, but when the blastic transformation occurs, many 
patients are lost due to infections and hemorrhagic complications. 
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Background. The corpus callosum comprises the largest tract of nerve fibres in the human brain. 
It is developed from the telencephalon starting in the 11th week of foetal life. Partial or complete 
agenesis of the corpus callosum is a rare developmental anomaly of unknown cause. A case of 
corpus callosum agenesis is described.  
Case report. The patient was a small for gestational age (1950g) female infant delivered at 35 
weeks. In view of multiple congenital abnormalities (bilateral choanal atresia, atrial septal defect, 
ventricular septal defect and facial dysmorphism), chromosome studies were done and showed 
partial monosomy of chromosome 13 (46,XX, del (13)(q22q33) ). Head ultrasound and cranial 
CT scan was performed which found appearances typical of agenesis of the corpus with 
ascension of the third ventricle and increased distance between lateral ventricles, cerebellar 
hemispheres and vermis atrophy, cisterna magna and fourth ventricle dilatation. After the 
surgical intervention for bilateral choanal atresia, a cranial ultrasound was performed and 
confirmed the atresia of the corpus callosum, but the path of anterior cerebral artery showed on 
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color Doppler suggests the existence of the rostrum. The patient was carefully monitored after 
the surgery. 24 days after the surgery the general status of the patient becomes altered, the patient 
presenting jet vomiting and nystagmus. The transfontanellar ultrasound showed 
ventriculomegaly with intracranial pressure (IR: 0.79->0.95) and the lumbar puncture showed 
transparent, sterile cerebrospinal fluid for which she remains carefully monitored.  
Conclusions. Although rare, agenesis of the corpus callosum is easely recognisable on CT scan 
and neonatal ultrasound. Even it is itself asymptomatic, may be associated with other 
malformations, especially in genetic syndromes, playing an important role in the production of 
neurological symptoms. 
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Background. Atypical chronic myeloid leukemia (aCML), BCR-ABL1 negative is a rare 
myelodysplastic syndrome (MDS)/myeloproliferative neoplasm (MPN) for which no current 
standard of care exists. ACML is characterized by many clinical features (splenomegaly, myeloid 
predominance in the bone marrow with some dysplastic features but without a differentiation 
block) and laboratory abnormalities (myeloid proliferation, low leukocyte alkaline phosphate 
values). A review of the literature suggests that the presence of an abnormal chromosome 21 may 
predispose to the development of leukemia.  
Case report. A 41-year-old man with a past medical history of Down syndrome (47, XY, +21) 
was admitted to the Haematology Unit of Mures Country Emergency Hospital with severe 
anemia, thrombocytopenia and leukocytosis. Following the peripheral smear, bone marrow 
biopsy and RT-PCR for bcr/abl (negative) indicated atypical chronic myeloid leukemia or 
myelodysplastic syndrome(MDS)/myeloproliferative neoplasm(MPN) grade III. The substitution 
treatment was established and the condition of the patient has evolved unfavorably with 
bronchopneumonia, respiratory failure, diffuse micropapous rash and Clostridium colitis. Due to 
chromosomal abnormality the cytostatic treatment is difficult to administer. The RT-PCR for 
JAK2, cMPL, CALR was negative. The final diagnosis falls as a myeloid neoplasia associated 
with Down syndrome with blasts lower than 20% at the medullary level, but in terms of WHO 
classification, the blastic percentage is not relevant. Therefore, the treatment chosen was mild 
cytoreduction (ARA-C) and substitution depending on tolerance, but even with the correctly 
administered treatment the patient died after ten months. 
Conclusions. In conclusion, atypical chronic myeloid leukemia is a rare disease and the 
association with chromosomal abnormalities and the lack of standards of care is a challenge in 
treating these patients and poor results should be expected.  
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